Brett A. Wall - 28 Jul 2025 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Pres Neuroscience
Signature
/s/ Patricia Walesiewicz, attorney-in-fact
Issuer symbol
MDT
Transactions as of
28 Jul 2025
Transactions value $
$0
Form type
4
Filing time
30 Jul 2025, 16:29:12 UTC
Previous filing
27 Jan 2025
Next filing
04 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wall Brett A. EVP & Pres Neuroscience 710 MEDTRONIC PARKWAY, MINNEAPOLIS /s/ Patricia Walesiewicz, attorney-in-fact 30 Jul 2025 0001473812

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $0 +9.79K +23.58% $0.00 51.3K 28 Jul 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Award $0 +24.5K $0.00 24.5K 28 Jul 2025 Performance Share Unit 24.5K Direct F3, F4, F5
transaction MDT Stock Option (Right to Buy) Award $0 +69K $0.00 69K 28 Jul 2025 Ordinary Shares 69K $91.97 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
F2 Includes 517 shares acquired through dividend reinvestment since the last report filed by the reporting person.
F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F4 Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.
F5 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,465 shares will be issued. If maximum performance metrics are achieved, 48,930 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F6 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.